Oakworth Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Sell |
1,426
-2,803
| -66% | -$232K | 0.01% | 270 |
|
|
2025
Q1 | $343K | Sell |
4,229
-1,463
| -26% | -$119K | 0.02% | 152 |
|
|
2024
Q4 | $513K | Sell |
5,692
-271
| -5% | -$24.4K | 0.04% | 122 |
|
|
2024
Q3 | $589K | Buy |
5,963
+242
| +4% | +$23.9K | 0.04% | 113 |
|
|
2024
Q2 | $530K | Sell |
5,721
-154,812
| -96% | -$14.4M | 0.04% | 117 |
|
|
2024
Q1 | $15.2M | Sell |
160,533
-4,541
| -3% | -$431K | 1.15% | 23 |
|
|
2023
Q4 | $14.7M | Buy |
165,074
+2,563
| +2% | +$229K | 1.18% | 20 |
|
|
2023
Q3 | $11.9M | Sell |
162,511
-8,582
| -5% | -$627K | 1.08% | 22 |
|
|
2023
Q2 | $14.2M | Sell |
171,093
-286
| -0.2% | -$23.8K | 1.21% | 21 |
|
|
2023
Q1 | $13.1M | Buy |
171,379
+1,075
| +0.6% | +$81.9K | 1.17% | 23 |
|
|
2022
Q4 | $14.1M | Sell |
170,304
-2,858
| -2% | -$237K | 1.36% | 18 |
|
|
2022
Q3 | $13.7M | Buy |
173,162
+853
| +0.5% | +$67.7K | 1.52% | 17 |
|
|
2022
Q2 | $12.8M | Buy |
+172,309
| New | +$12.8M | 1.29% | 19 |
|
|
2019
Q4 | – | Sell |
-210
| Closed | -$16K | – | 585 |
|
|
2019
Q3 | $16K | Hold |
210
| – | – | ﹤0.01% | 401 |
|
|
2019
Q2 | $18K | Hold |
210
| – | – | ﹤0.01% | 438 |
|
|
2019
Q1 | $19K | Hold |
210
| – | – | ﹤0.01% | 396 |
|
|
2018
Q4 | $15K | Hold |
210
| – | – | ﹤0.01% | 407 |
|
|
2018
Q3 | $20K | Hold |
210
| – | – | ﹤0.01% | 393 |
|
|
2018
Q2 | $20K | Hold |
210
| – | – | ﹤0.01% | 396 |
|
|
2018
Q1 | $18K | Hold |
210
| – | – | ﹤0.01% | 383 |
|
|
2017
Q4 | $17K | Buy |
+210
| New | +$17K | ﹤0.01% | 403 |
|